Education & Training

Search for Educational Activities:

Filter by Target Audience

Please select the option that best aligns with your profession.

Filter by Topic

Please select the option that best aligns with your topic of interest.

If a subtopic exists for your primary topic, it will automatically display below.

Filter by Format

Please select the option that best aligns with your preferred format of training.

PCSS has the resources and training you need
to meet the needs of your patients.

PCSS is a national training and clinical mentoring project developed in response to the opioid use disorder crisis. Made up of a coalition and led by the American Academy of Addiction Psychiatry (AAAP), PCSS’s education and training resources are developed for healthcare providers and professionals. The overarching goal of PCSS is to provide the most effective evidence-based clinical practices in the prevention of OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.

Joint Accreditation: Interprofessional Continuing Education: Education for the team, by the team

Jointly Accredited Provider

In 2019, American Academy of Addiction Psychiatry was approved as a provider of Joint Accreditation for Interprofessional Continuing Education™. Joint Accreditation is the leading model of interprofessional collaboration that helps improve healthcare through continuing education for the team, by the team. Joint Accreditation offers us the opportunity to be simultaneously accredited to provide medicine, pharmacy and nursing continuing education activities through a single, unified application process, fee structure and set of accreditation standards, from these three global leaders in the field of accreditation: Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and American Nurses Credentialing Center (ANCC). By offering three accreditations in one review process, Joint Accreditation promotes interprofessional continuing education activities specifically designed to improve interprofessional collaborative practice in health care delivery. Learn more about Joint Accreditation.

Educational Activities by Format


Designed to enhance providers knowledge and skills in evidence-based treatment practices. Most include CME/CE credit and all offered at no cost.


The PCSS Podcasts provides insight into challenges around opioid use disorders and pain management.


Videos address an array of topics including: stigma, engaging patients and treatment options.


Webinars address a wide range of topics related to clinical practices. Most include CME/CE credit and all are offered at no cost.


These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.

Note: Inclusion on the list does not indicate PCSS, AAAP, or partner organizations endorse any of the resources listed and exclusion in no way implies other resources are not available or valuable.

Assessing and managing pain while evaluating risks associated with substance use and substance use disorders continues to be a challenge faced by health care clinicians. The American Society for Pain Management Nursing and the International Nurses Society on Addictions uphold the principle that all persons with co-occurring pain and substance use or substance use disorders have the right to be treated with dignity and respect, and receive evidence-based, high quality assessment, and management for both conditions. The updated position statement and practice recommendations will be discussed to guide care of all patients and those with SUD increased risk.
The purpose of this guide is to provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids. 
Opioid use disorder (OUD) can be a fatal addiction with complex implications for new and/or expecting mothers. OUD challenges can lead to many complications for mother and child, including low birth weight, clinical challenges with medical dosing and increased risk of accidental death. In the U.S. alone, a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child, policies must allow engagement in evidence-based treatment and protect clients from legal ramifications. Hear from a physician, clinic director and an individual with lived experience to broaden understandings about the treatment and policy landscape for pregnant and postpartum women with OUD.
Escalation of perinatal opioid overdose and mortality has become a national public health concern. Prescription opioids are considered a gateway drug to misuse and dependency of other illicit drugs such as fentanyl and heroin. This study explored the 1) the pain-related experiences, 2) the social-ecological factors and experiences, and 3) the healthcare-related experiences of perinatal women who used or misused prescription opioids. The women’s shared experiences provided insights regarding how socio-ecologic and healthcare-related factors intersected with their pain experiences, which will be presented in three major themes of the study. This intersection was collectively identified as contributing to their initiation and perpetuation of misuse which hindered their journey to recovery and motherhood.
Join the ADA and Providers Clinical Support System (PCSS) to learn how dental professionals can describe safe pharmacological management of acute dental pain, propose conversations and education for opioid use and misuse and the need for referral of patients and providers. Kimberly A. Sanders Pharm.D., and David Lesansky D.M.D. will share their expertise and answer questions. Attendees will learn safe pharmacological management of acute dental pain and propose conversations and education for opioid use and misuse. Presenters will review the need for referral of patients and providers at risk of substance use and misuse and the need for intervention.
This presentation will explore data from the University of Vermont Center on Rural Addiction’s Baseline Needs Assessments in Vermont, New Hampshire, and Maine, sharing insights gathered from practitioners and stakeholders about their concerns about opioid use and their perceived barriers to and beliefs about opioid use disorder treatment.
This webinar will review the current state of the opioid crisis in the U.S., the factors that influenced it and ways that healthcare providers can help their patients make optimum choices regarding the use of nonopioid options for anesthesia and analgesia.
Rachel Talley, MD, and Jessica Isom, MD
The opioid crisis continues to have a devastating impact on families and communities across the United States. Individuals from marginalized communities, including Black, Indigenous and People of Color (BIPOC) communities and individuals who are uninsured or have lower incomes, with opioid use disorders (OUD) often experience challenges accessing and sustaining treatment services. Many of these challenges stem from unaddressed social determinants of health factors (housing, education, geography etc.) as well as systemic inequities across all care settings. Lack of attention to these factors can lead to inadequate care for OUD and inadequate support for long-term recovery.
Youth experiencing homelessness (YEH) have unique risks and struggles, including opioid and other drug use. With 79% of study samples reporting opioid use and 52% reporting drug-related overdose, the opioid epidemic has disproportionately affected youth who are homeless. Housing First interventions employ housing as a basic human right and assert that housing should be provided first, regardless of engagement in other treatments. While a unique opioid prevention intervention, housing first strategies serve as a baseline for other beneficial interventions targeting drug use. Hear the results of a randomized controlled trial administered by Ohio State University in Columbus, OH.
Loading more results